Skip to content

Clinical study to evaluate efficacy of sahachar oil matra basti in management of gridhrasi (sciatica )

Clinical study to evaluate efficacy of sahachar tail matra basti in management of gridhrasi - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/01/061202
Enrollment
25
Registered
2024-01-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M543- Sciatica

Interventions

None listed

Sponsors

Tilak ayurved mahavidyalaya pune
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient with age group 30 to 60 years 2.Patient having minimum 3 signs and symptoms of gridhrasi i.e shool, sthambha, toda, graha, gridhravatachalan, kaphaj lakshanas- tandra, gaurava, vanhimardava,bhaktadwesh.

Exclusion criteria

Exclusion criteria: 1.Patients who are contraindicated for basti as per brihatrayi. 2.Mentruating womens, medical conditions related to female reproductive system, pregnant and PNC patients. 3.Patients having spinal deformities, severe traumatic injury to spinal cord and having unbearable pain 4.Patients having chronic and major illness like cardiac, renal, autoimmune diseases etc. 5.known sero positive 6. known potts spine, acute vertebral disc prolapse, bamboo spine, vertebral fusion 7. any abdominal surgical procedures

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of sahachar tail matra basti in management of gridhrasiTimepoint: 7 days

Secondary

MeasureTime frame
shoola, stambha, toda, spandan, graha, tandra, aruchi, gaurav, slr test, slump test, oxford pain chart, walking time.Timepoint: 14 days

Countries

India

Contacts

Public ContactVd Rajendra S Huparikar

Tilak ayurved mahavidyalaya,pune

ayurvedapune@gmail.com9823050402

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026